Concord Wealth Partners’s Repligen RGEN Stock Holding History

Concord Wealth Partners’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10	Closed	-$1.44K	–	941
2024 Q4	$1.44K	Hold	10	–	–	﹤0.01%	745
2024 Q3	$1.49K	Hold	10	–	–	﹤0.01%	783
2024 Q2	$1.26K	Hold	10	–	–	﹤0.01%	706
2024 Q1	$1.84K	Hold	10	–	–	﹤0.01%	759
2023 Q4	$1.8K	Hold	10	–	–	﹤0.01%	723
2023 Q3	$1.59K	Hold	10	–	–	﹤0.01%	901
2023 Q2	$1.42K	Hold	10	–	–	﹤0.01%	909
2023 Q1	$1.68K	Hold	10	–	–	﹤0.01%	840
2022 Q4	$1.69K	Buy	+10	New	+$1.81K	﹤0.01%	979
2022 Q3	–	Sell	-10	Closed	-$2K	–	912
2022 Q2	$2K	Hold	10	–	–	﹤0.01%	1052
2022 Q1	$2K	Hold	10	–	–	﹤0.01%	1126
2021 Q4	$3K	Hold	10	–	–	﹤0.01%	1073
2021 Q3	$3K	Hold	10	–	–	﹤0.01%	705
2021 Q2	$2K	Hold	10	–	–	﹤0.01%	911
2021 Q1	$2K	Hold	10	–	–	﹤0.01%	848
2020 Q4	$2K	Buy	+10	New	+$1.82K	﹤0.01%	562

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Concord Wealth Partners's RGEN Position: Q1 2025 in Review

Concord Wealth Partners sold out of Repligen (RGEN) in Q1 2025, closing a stake of 10 shares — an estimated $1.44K sold.

Concord Wealth Partners first reported a position in RGEN in Q4 2020 and held it in 16 quarters. The position peaked at $3K in Q4 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

Concord Wealth Partners reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
Concord Wealth Partners sold 10 Repligen shares in Q1 2025, an estimated $1.44K.
Concord Wealth Partners first reported a position in Repligen in Q4 2020 and held it in 16 quarters.
Concord Wealth Partners's Repligen position peaked at $3K in Q4 2021.
442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Concord Wealth Partners's 13F filing for Q1 2025, filed 2 May 2025.